Bond.az White LogoBond.az Black Logo

FuriosaAI Partners with Broadcom on 3rd Gen AI Chip

FuriosaAI partners with Broadcom to develop 3rd gen AI chip with 2nm process and HBM4 memory. Sampling starts H1 2028.

Harper Clark
ByHarper Clark- Senior Editor
|
0

MOUNTAIN VIEW, Calif. - FuriosaAI announced a partnership with Broadcom to develop its third-generation AI accelerator chip.

The collaboration combines FuriosaAI's Tensor Contraction Processor architecture with Broadcom's networking technology to create a multi-die chiplet system for AI inference workloads in data centers.

FuriosaAI's current product, RNGD, is a 180-watt, PCIe-based accelerator manufactured using TSMC's 5nm process. The chip is in mass production and deployed by Samsung SDS and LG AI Research.

"Inference performance is no longer defined solely by raw compute. It is increasingly a function of data reuse and communication efficiency across servers and racks," said Charlie Kawwas, president of Broadcom's Semiconductor Solutions Group.

The third-generation chip will feature a 2nm compute die and HBM4/4E memory, using Broadcom's packaging technology to integrate multiple silicon dies.

"Having proven the performance and efficiency of our architecture with RNGD, our second-generation chip now in mass production with TSMC, we will deliver a third-generation inference solution," said June Paik, FuriosaAI cofounder and CEO.

Sampling of the third-generation chip is scheduled to begin in the first half of 2028.

More News
2026-06-01 12:34
|
401

Amber International shareholder to distribute stake pro rata

Amber International's principal shareholder distributes all Class A shares pro rata to existing shareholders; market impact and financial highlights.

0
2026-06-01 12:33
|
213

Palladyne AI Adds Two Retired Generals to Board

Palladyne AI appoints two retired generals to its defense advisory board. Stock up 98% YTD.

0
2026-06-01 12:32
|
381

Cellectar Plans Phase 3 Trial for WM After BTKi

Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.

0
2026-06-01 11:33
|
363

essensys Shareholders Approve Re-Registration as Private Company

essensys shareholders approve re-registration as a private company after AIM delisting. All voting shareholders backed the resolution.

0
2026-06-01 08:31
|
890

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
2026-06-01 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
2026-06-01 07:33
|
417

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

0
2026-06-01 07:31
|
226

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

0
2026-06-01 07:30
|
762

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
2026-06-01 07:04
|
680

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
2026-06-01 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
2026-06-01 07:00
|
543

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
...
FuriosaAI Partners with Broadcom on 3rd Gen AI Chip | Bond.az